Article
BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.
Annals of surgical oncology - 1 Jan 2013
Howell Gina M, Nikiforova Marina N, Carty Sally E, Armstrong Michaele J, Hodak Steven P, Stang Michael T, McCoy Kelly L, Nikiforov Yuri E, Yip Linwah
Abstract excerpt
PURPOSE: This study was designed to examine whether available preoperative clinical parameters, including B-type Raf kinase (BRAF) V600E mutation status, can identify patients at risk for central compartment lymph node metastasis (CLNM). METHODS: Under an institutional review board-approved protocol, we conducted a single-center, retrospective review of all patients who had initial thyroidectomy for histologic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
